156 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ARRY Array BioPharma Inc. $13.73 $2.91B N/A
Article Searches
ROTY Edition 1 Volume 64: Several Key Updates And Trades https://seekingalpha.com/article/4132706-roty-edition-1-volume-64-several-key-updates-trades?source=feed_tag_etf_portfolio_strategy Dec 19, 2017 - While performance for December continues to disappoint, we continue to position the ROTY model account for a profitable 2018.Argenx received a very large price hike from an analyst.Global Blood Therap
Arris sinks after warning of continuing memory pricing pressure https://seekingalpha.com/news/3318480-arris-sinks-warning-continuing-memory-pricing-pressure?source=feed_news_all Dec 14, 2017 - Arris (NASDAQ:ARRS) fell 6.3% today and touched its lowest point since early September after holding a call where it said it expects margin pressures from memory pricing to stretch some distance into
Are Options Traders Betting on a Big Move in Array BioPharma (ARRY) Stock? http://www.zacks.com/stock/news/285513/are-options-traders-betting-on-a-big-move-in-array-biopharma-arry-stock?cid=CS-ZC--285513 Dec 11, 2017 - Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.
Array BioPharma: Expecting Significant Upside In 2018 https://seekingalpha.com/article/4129177-array-biopharma-expecting-significant-upside-2018?source=feed_all_articles Dec 02, 2017 - Shares have risen a decent bit since my initial entries, but I believe 2018 holds substantially more upside ahead.Below I provide a recap of the bullish thesis and recent events.After its September se
Is the Options Market Predicting a Spike in Array BioPharma (ARRY) Stock? http://www.zacks.com/stock/news/283549/is-the-options-market-predicting-a-spike-in-array-biopharma-arry-stock?cid=CS-ZC-FT-283549 Nov 21, 2017 - Investors need to pay close attention to Array BioPharma (ARRY) stock based on the movements in the options market lately.
Steven Cohen Takes Stake in Karyopharm Therapeutics http://www.gurufocus.com/news/590952/steven-cohen-takes-stake-in-karyopharm-therapeutics Nov 07, 2017 - Steven Cohen Takes Stake in Karyopharm Therapeutics, Stocks: KPTI,ADMS,ONCS,GBT,ARRY,PCRX,AKAO, Steven Cohen, release date:Nov 07, 2017
Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood http://www.gurufocus.com/news/574874/steven-cohen-doubles-down-on-sickle-cell-disease-therapeutics-company-global-blood Oct 04, 2017 - Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood, Stocks: GBT,ARRY,PCRX,AKAO, Steven Cohen, release date:Oct 04, 2017
Ono Pharmaceutical Needs To Reinvest Its Windfall https://seekingalpha.com/article/4110766-ono-pharmaceutical-needs-reinvest-windfall?source=feed_sector_healthcare Oct 03, 2017 - Ono is reaping the benefits of Opdivo's growth, but there is ample competition in the PD-1 space, and growth will be tied to clinical success, competitors' results, and government pricing.Ono's intern
Week 39 Breakout Forecast: Short-Term Picks To Give You An Edge https://seekingalpha.com/article/4109002-week-39-breakout-forecast-short-term-picks-give-edge?source=feed_all_articles Sep 24, 2017 - Four new breakout stocks for Week 39 with better than 10% short-term upside potential. Continuing a 13 week streak of at least one stock gaining greater than 10% in the first 5 days of trading.  (26 o
Own Altria For The Dividend - Cramer's Lightning Round (9/20/17) https://seekingalpha.com/article/4108484-altria-dividend-cramers-lightning-round-9-20-17?source=feed_all_articles Sep 21, 2017 - Book partial profits on STMicroelectronics.Intercept Pharmaceuticals is a speculative biotech with positive news.Array BioPharma has the money to expand its portfolio.

Pages: 1...5678910111213141516

<<<Page 10>